Effect of Botulinum Toxin Type A Combined with Intradermal Hypertension Suture in the Treatment of Pathological Scars
Objective:To investigate the effect of Botulinum Toxin Type A combined with intradermal hypertension suture in the treatment of pathological scar.Method:The clinical data of 62 patients with pathological scar admitted to Ganzhou People's Hospital from March 2021 to March 2023 were retrospectively analyzed.They were divided into two groups according to different treatment methods,with 31 cases in each group.The control group underwent intradermal hypertension suture,and the experimental group underwent Botulinum Toxin Type A combined with intradermal hypertension suture.Vancouver scar rating scale(VSS)score,observer scar assessment scale(OSAS)score,scar width,scar thickness,incidence of incision adverse reactions and recurrence were compared between the two groups.Result:Before surgery,there were no statistical significance in OSAS score,VSS score,scar width and scar thickness between the two groups(P>0.05).At 6 months after surgery,OSAS score,VSS score,scar width and scar thickness between the two groups were lower than those before surgery,and those in the experimental group were lower than those in the control group,the differences were statistically significant(P<0.05).There was no significant difference in the incidence of postoperative incision adverse reactions between the two groups(P>0.05).The recurrence rate of experimental group was 3.23%,which was lower than 19.35%of control group,the difference was statistically significant(P<0.05).Conclusion:Botulinum Toxin Type A combined with intradermal hypertension suture can effectively promote the wound healing of patients with pathological scars,improve the aesthetic of the incision,reduce the degree of scar formation,and reduce the recurrence rate.
Vancouver scar evaluation scaleObserver scar assessment scaleBotulinum Toxin Type AIntradermal hypertension sutureScar
国家科技期刊平台
NSTL
万方数据
